Retatrutide is a synthetic peptide and the first known triple agonist of the GLP-1, GIP, and Glucagon receptors. It has shown promising results in early research for its potential to improve weight loss, insulin sensitivity, and overall metabolic function.
Retatrutide 10mg
Triple Agonist
Retatrutide is a novel triple agonist peptide targeting GLP-1, GIP, and Glucagon receptors. It is being studied for its potential in weight management, metabolic health, and glycemic control.




Reviews
There are no reviews yet.